AstraZeneca Posted August 4, 2026

Executive Director, Head of Cell Therapy Non-Clinical Safety Lead, Cell Therapy Translational and Safety Sciences.

Gaithersburg, Maryland, United States of America Full time
Clinical Development Executive/VP

AstraZeneca is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

At AstraZeneca, we’re not afraid to do things differently. We’re building a new kind of organization to reset expectations of what a bio-pharmaceutical company can be. This means we’re opening new ways to work, pioneering cutting edge methods and bringing unexpected teams together.  We believe in the potential of our people, and you’ll develop beyond what you thought possible. We make the most of your skills and passion by actively supporting you to ensure realization of your potential. You’ll join an energized team and work on projects that offer a wide range of on-going learning and career development opportunities.

Are you passionate about shaping the future of Cell Therapy? We are seeking an entrepreneurial leader to head our Nonclinical Safety Sciences team in our new global multi-functional Cell Therapy Translational and Safety Sciences group.  As the Nonclinical Safety Sciences Head, you will play a crucial role in bringing the next generation of innovative life-changing medicines to patients. You will oversee a team of toxicologists and laboratory-based specialists to influence and enable the design and development of safe cell therapies across multiple modalities and therapeutic areas.   You will report to the VP of Cell Therapy Translational and Safety Sciences (CT-TSS) and will become a member of the CT-TSS Leadership Team contributing to both, strategy and operational discussions and initiatives.

Key Responsibilities:

•    Lead global team of toxicologists and laboratory-based specialists to design and deliver safe cell therapies, across different platforms (autologous, allogeneic, in vivo), engineered with CAR-T and TCR-T, and across therapeutic areas.•    Ensure appropriate resource allocation and program and project prioritization for timely delivery towards a dynamic and expanding cell therapy portfolio. Provide oversight and guidance to enable project and portfolio investment decisions.•    Lead and manage talent development, recruitment and evaluate team performance on a regular basis. Promote inclusion and diversity to build high-functioning teams within and across departments. Align to AZ’s culture and values and further solidify our reputation as a great place to work.  •    As a seasoned subject matter expert in Nonclinical Cell Therapy Safety, use experience, expertise and leadership to influence Cell Therapy Safety Science project strategies. Anticipate and manage potential project-related nonclinical safety concerns and support global regulatory submissions and health authority requests.   •    Be responsible and accountable for Cell Therapy Safety Sciences strategy and deliverables.•    Build and promote collaborative and inclusive networks and workstreams to ensure alignment with key global stakeholders.   •    Initiate, lead and manage internal and external collaborations to access latest scientific developments and innovations, expanding business opportunities for the company resulting in enhanced impact and external scientific leadership in the field of cell therapy.  •    Performs business development-related asset, platform or technology evaluations .•    Perform evaluation and due diligence for in licensing, out-sourcing or collaboration opportunities.  •    Contribute to wider scientific strategy on cell therapy within the Cell Therapy Enterprise and cross-functionally with relevant partners in AZ.

Requirements:

•    PhD relevant field (Toxicology, Biology, Immunology) with over 10 years of experience.•    Excellent understanding of nonclinical safety sciences in the context of CAR-T & TCR cell therapies and proven prior experience in the field.  •    Extensive experience supporting nonclinical safety assessments of cell therapies, including different modalities and platforms (autologous, allogeneic, in vivo, etc), from target identification through clinical development.   •    Experience of global IND / BLA / IIT submissions, leading regulatory interactions within area of expertise and responding to global regulatory questions.   •    Proven and excellent experience in designing, developing and implementing cell therapy safety strategies.  •    Strong leadership skills and line management experience with a positive team engaging attitude and a track record in the leadership, management and talent development of individuals and teams.  •    Track record of leading impact on drug R&D within the pharmaceutical industry or biotech sector with a strong focus on safety assessment.•    Leader of collaborations with academia, biotech and / or pharma industry to enhance pre-clinical safety assessment of T-cell therapies.•    Track record of scientific innovation in the safety assessment arena  •    Recognized as a leader and influencer in the cell therapy field with proven track record of publishing relevant results and tools in journals, conferences, and other scientific proceedings.   In Office Requirement:  When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.   Why AstraZeneca?  At AstraZeneca when we see an opportunity for change, we seize it and make it happen, because any opportunity, no matter how small, can be the start of something big. Delivering life-changing medicines is about being entrepreneurial - finding those moments and recognizing their potential. Join us on our journey of building a new kind of organization to reset expectations of what a bio-pharmaceutical company can be. This means we’re opening new ways to work, pioneering cutting-edge methods and bringing unexpected teams together.

Interested? Come join our journey.

The annual base pay for this position ranges from $264,258.40 - $396,387.60 Our positions offer eligibility for various incentives, an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles. Benefits offered include qualified retirement programs, paid time off (i.e., vacation, holiday, and leaves), as well as health, dental, and vision coverage in accordance with the terms of the applicable plans.

Date Posted

04-Aug-2026

Closing Date

30-Aug-2026 Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.

Job details

Seniority
Executive/VP
Function
Clinical Development
Therapeutic area
Not listed
Location
Gaithersburg, Maryland, United States of America
Employment type
Full time

How this role compares

Computed from every other active Clinical Development role in our database, not just this employer's listings.

We currently track 53 comparable Executive/VP Clinical Development roles across 16 biopharma companies.

53Comparable roles tracked
49Currently active
16Companies hiring similar roles
6Countries represented

Salary context

33 of 53 peers report a salary range (USD, annualized)

Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.

This roleSubject Not listed on this posting
Lowest disclosed · Sr Director CDOS Process Owner - Clinical Trial Foundations · Lilly $156,000/yr – $228,800/yr
Highest disclosed · Global Clinical Head- Executive Director · AstraZeneca $331,874/yr – $497,810/yr
Peer group range $192,400 – $414,842 (median $329,250)

Where these roles are based

Top locations among the 53 comparable roles

United States47
China2
United Kingdom1
Switzerland1
India1
Denmark1

Seniority mix

53 of 53 peers have a known seniority level

Executive/VP32
Senior Director21

Therapeutic area mix

32 of 53 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology11
Respiratory5
Immunology5
Neuroscience4
Vaccines & Infectious Disease3
Cardiovascular / CVRM2
Gastroenterology1
Ophthalmology1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

60%similar
AstraZeneca Boston, Massachusetts, United States of America Executive/VP
Same function Same seniority Same country
60%similar
Alexion Boston, Massachusetts, United States of America Executive/VP
Same function Same seniority Same country
60%similar
AbbVie Executive/VP
Same function Same seniority Same country

Open in 5 locations

North Chicago, United StatesCambridge, United StatesFlorham Park, United StatesSouth San Francisco, United StatesIrvine, United States
60%similar
AbbVie North Chicago, IL Executive/VP
Same function Same seniority Same country
60%similar
AstraZeneca Gaithersburg, Maryland, United States of America Executive/VP
Same function Same seniority Same country
60%similar
AstraZeneca Boston, Massachusetts, United States of America Executive/VP
Same function Same seniority Same country

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

60%
Executive Medical Director, Gastroenterology, Early R&I Clinical Development
AstraZeneca · Boston, Massachusetts, United States of America · Executive/VP
Function Therapeutic area Seniority Country
60%
Executive Medical Director, Immunology Clinical Development - Respiratory/Pulmonary
AbbVie · Cambridge, MA · Executive/VP
Function Therapeutic area Seniority Country
60%
Executive Medical Director, Immunology Clinical Development - Respiratory/Pulmonary
AbbVie · Irvine, CA · Executive/VP
Function Therapeutic area Seniority Country
60%
Executive Medical Director, Clinical Development, Hematology
AstraZeneca · Boston, Massachusetts, United States of America · Executive/VP
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.